Le Lézard
Classified in: Health, Science and technology
Subject: AWD

American Society of Business Publication Editors (ASBPE) Recognizes Bloomberg Law Team with Prestigious Journalism That Matters Award


2024 Marks Only Fourth Time in 15 Years That ASBPE Elects to Bestow This Special Honor

ARLINGTON, Va., May 28, 2024 /PRNewswire/ -- Bloomberg Law today announced that the American Society of Business Publication Editors (ASBPE) awarded its reporters Julie Steinberg, Gary Harki, Celine Castronuovo, Stu Basu, and Alex Ruoff the Journalism That Matters Award, which recognizes "B2B journalists whose articles brought about change within their industries." The team was honored for its groundbreaking story, Baby Foods With Toxic Metals Stay on US Market While FDA Dithers, which investigated how heavy metals wind up in baby food. Since ASBPE first issued the award in 2009, this marks only the fourth time it has been bestowed.

ASBPE recognizes Bloomberg Law reporters for role in bringing about change in FDA guidelines around lead in baby foods.

Two weeks after the story was published, and after at least nine months of delays, FDA released new guidelines around lead in baby foods. Post-publication, the FDA removed its timeline for more actions. A joint letter from members of the House and the Senate subsequently wrote a letter to the agency citing Bloomberg Law's investigation, demanding action, and questioning the FDA's lack of progress.

"To tell a story this important, we leveraged the talent and strengths of journalists from across the entire Bloomberg Industry Group newsroom," said Cesca Antonelli, editor-in-chief, Bloomberg Industry Group. "We also knew that effecting real change would require us to go the extra mile, and so we commissioned independent analysis of 33 different baby food products as part of our reporting. The result is a story that shed light on a problem hiding in plain sight and caused people to take notice and demand action. Congratulations to Julie, Gary, Celine, Stu, Alex and the rest of the members of our newsroom who helped make this story a success."

The story is accessible online at https://aboutblaw.com/beb5. Information about the award is available at https://asbpe.org/asbpe-awards/.

About Bloomberg Law 
Bloomberg Law combines the latest in legal technology with workflow tools, comprehensive primary and secondary sources, trusted news, expert analysis, and business intelligence. For more than a decade, Bloomberg Law has been a trailblazer in its application of AI and machine learning. Bloomberg Law's deep expertise and commitment to innovation provide a competitive edge to help improve attorney productivity and efficiency. For more information, visit?Bloomberg Law

SOURCE Bloomberg Law


These press releases may also interest you

at 12:14
CapitaLand Investment Limited (CLI) has incorporated three new Scope 3 categories deemed material to its operations ? Purchased goods and operations, Fuel- and energy-related activities, and Upstream transportation and distribution ? and expanded the...

at 10:47
CapitaLand Investment Limited (CLI) has incorporated three new Scope 3 categories deemed material to its operations ? Purchased goods and operations, Fuel- and energy-related activities, and Upstream transportation and distribution ? and expanded the...

at 10:45
Sungrow, the global leading PV inverter and energy storage system provider, shared 10 major technological trends at the recent Ph.D Talk event in Shanghai. With an investment of 2.45 billion yuan (approximately 347 million) in R&D throughout 2023,...

at 10:36
On June 6, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), in collaboration with China Mobile, unveiled the world's first 800G hollow-core fibre transmission test network in Shenzhen-Dongguan, Guangdong. The development is a...

at 10:30
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equecabtagene Autoleucel (Eque-cel),...

at 10:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi® (glofitamab-gxbm) in combination with gemcitabine and...



News published on and distributed by: